Skip to main content
TipRanks
Go Ultimate75% OFF

EyePoint Pharmaceuticals (PV3B) Q2 2023 Earnings Report

1 Followers

DE:PV3B Q2 2023 EPS Results

Actual EPS
-EUR 0.56
Consensus EPS
EUR 1.26
Beat/Miss
Missed by -EUR 1.82
One Year Ago EPS
-EUR 0.47

DE:PV3B Q2 2023 Revenue Results

Actual Revenue
EUR 8.30M
Expected Revenue
EUR 72.11M
Beat/Miss
Missed by -EUR 63.81M
YoY Revenue Growth
-21.27%

Earnings Announcement Details

Quarter
Q2 2023
Date
08/02/2023
Time
Before Open
Conference Call
Wednesday, August 2, 2023
DE:PV3B Upcoming Earnings

EyePoint Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q2 2023 Earnings Call Audio

DE:PV3B Q2 2023 Earnings Call
0:00 / 0:00

Q2 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:PV3B Earnings History

DE:PV3B earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)-0.63--0.74――
Nov 12, 20262026 (Q3)-0.85-0.98-0.77-25.88% (-0.20)
Aug 05, 20262026 (Q2)-0.90-0.99-0.77-28.24% (-0.22)
May 06, 20262026 (Q1)-0.73-0.90-0.59-52.31% (-0.31)
Mar 04, 20262025 (Q4)-0.68-0.74-0.58-26.56% (-0.15)
Nov 05, 20252025 (Q3)-0.70-0.77-0.49-57.41% (-0.28)
Aug 06, 20252025 (Q2)-0.75-0.77-0.53-46.55% (-0.25)
May 07, 20252025 (Q1)-0.61-0.59-0.5-18.18% (-0.09)
Mar 05, 20252024 (Q4)-0.44-0.58-0.3-93.94% (-0.28)
Nov 07, 20242024 (Q3)-0.50-0.49-0.3-63.64% (-0.19)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed